Brightmeds review

Brightmeds publishes month-to-month compounded semaglutide at $129 and tirzepatide at $149, alongside lower monthly equivalents for packs prepaid for three months. Its GLP-1 subscription policy expressly defines billing as monthly, starting on the subscription or renewal date. A guarantee’s separate definition of a four-week medicine supply does not turn the charge schedule into every 28 days. The offer says the price covers the prescribed medication, provider oversight and standard shipping. Optional services, expedited delivery and ancillary fees have their own conditions. Compare the complete offer using the semaglutide cost guide.

The current GLP-1 offer has narrower conditions than a general company-wide availability statement. It lists 38 states plus DC, says no laboratory or separate prescribing fee applies to that offer, and identifies B6 as its additive. Other additives may have different prices depending on the state. Customers already using a GLP-1 or transferring a prescription are told to contact support for pricing. Ask which offer applies to your actual product, whether the first and later orders have the same terms and how the three-month pack renews. A discounted monthly equivalent is not a promise of a cancellable monthly payment.

Payment begins with an authorization hold rather than necessarily an immediate captured charge. The subscription policy says review is typically within 24 hours, but permits automatic capture if the decision remains pending after five days. If the clinician does not approve treatment, held or captured money is returned, with captured refunds generally taking five to ten business days. If approved, the patient must read the prescription notice in the portal and request any change before shipping. This is care arranged through independent clinical organizations: the general terms name M & D Integrations and TelegraMD, while the telehealth consent names OpenLoop Healthcare Partners. Ask which clinician and organization are responsible for your own treatment. Neither a payment hold nor a promotional acceptance message guarantees a prescription.

The subscription policy requires cancellation at least five business days before renewal, through the dashboard, email or phone. Canceling after a medicine has been compounded, dispensed or shipped does not stop that order’s charge. Promotional price-lock wording applies only while the subscription remains continuously active; canceling or interrupting it can lose that rate. Other prepaid offers need their own renewal and refund confirmation. Brightmeds describes U.S. state-licensed pharmacies chosen by state but does not identify the location assigned to every order. Its separate outcome guarantee has detailed reporting and coaching conditions and a days 168–190 request window; it also uses both 168 and 180 days of continued treatment. Confirm that conflict before relying on a refund. The guarantee is a commercial remedy, not evidence of an individual outcome.

The decision is therefore about documented service and financial terms as well as the medicine. Ask which clinician reviews the intake, whether a live appointment is available, which pharmacy supplies the preparation and what happens if side effects interrupt a prepaid course. Compounded preparations are not FDA-approved. A guarantee does not establish that an individual will achieve a particular result. Use the billing checklist and pharmacy checklist to organize those answers. The semaglutide lineup compares programs with documented terms without converting an unresolved billing interval into a price recommendation.